Introduction
Because their transparent bodies make it easy to observe tissue and neuron development in vivo, zebrafish, Danio rerio, is widely used as a model organism for investigating of the genetic control of early morphogenesis. Moreover, recent advances in systematically compiling information on sequences of the whole genome and on expressed sequence tags (ESTs) with expression patterns of individual genes have made identification and characterization of novel genes easier than ever. A gene 'knockdown' technology using antisense morpholino oligonucleotides was recently developed to facilitate the functional assignment of genes [1] . As an alternative and complement to this powerful approach, we previously reported the mRNA-caging technology using 6-bromo-4-diazomethyl-7-hydroxycoumarin (Bhc-diazo), which allows the study of gene function in a both a temporal-and spatial-specific manner [2] .
Caging of mRNA with Bhc-diazo was achieved by simply mixing the two compounds in DMSO, where Bhc-diazo reacts with the phosphate moiety of mRNA to yield 6-bromo-7-hydroxycoumarin-4-ylmethyl ester of phosphates. Bhc-caged mRNA loses almost all translational activity, but illumination with 350 through 365 nm ultraviolet (UV) light removes the Bhc-diazo group from the caged mRNA, resulting in the recovery of translational activity. Although the reaction involved in mRNA caging with Bhc-diazo is very simple, there are several points at which special care in the handling of the caged mRNA is needed for successful experiments. In this paper we describe detailed procedures for preparation of Bhc-diazo-caged mRNA and for its use in ectopic gene induction experiments.
Materials
Bhc-diazo. Bhc-diazo is supplied upon request by Dr. Toshio Furuta of the Department of Biomolecular Science, Toho University (furuta@biomol.sci.tohou.ac.jp).
Plasmids and mRNA. To synthesize mRNA for caging in vitro from full-length cDNAs which encoded GFP and β-galactosidase in pCS2 vector, we used a mMESSAGE mMACHINE (Ambion, USA). The mRNA pellets obtained were stored in 80% ethanol at -80 °C. mRNA was dissolved in RNasefree water at a concentration of 1 µg/µl just before use.
Room illumination. All procedures treating Bhc-diazo and caged mRNA were performed under UV-free conditions. We used fluorescent lamps laminated with UV-shielding film which were developed for use in the semiconductor industry and were available from various manufacturers, e.g., Toshiba supplies a lamp (FLR40S. Y/M.P.NU) that emits light with wave-lengths longer than 450 nm. Tubes made of UV-shielding film can be purchased from the same company and are easily used to laminate conven- Abstract. We previously reported mRNA caging technology as a novel and simple technique for photo-mediated temporal and spatial control of gene activation in zebrafish embryos and as an alternative to the 'gene knockdown' approach using antisense morpholino oligonucleotides. The caging reagent used is 6-bromo-4-diazomethyl-7-hydroxycoumarin (Bhc-diazo), which forms a covalent bond with the phosphate moiety of the sugar-phosphate backbone of RNA. Mainly because of the reduced solubility Key words: Bhc-diazo, Caged mRNA, Caging, Ectopic gene expression, Zebrafish of caged mRNA in aqueous solutions, special care in handling is needed. The Bhc-diazo group binds to the phosphate moieties of RNA and abolishes the translational activity of the latter. The translational activity of Bhc-caged mRNA is restored by photolysis/uncaging when exposed to long-wave UV light (350~365 nm). In this paper we describe the technique and detailed procedures for spatially and temporally controlled induction of gene expression in zebrafish embryos.
tional fluorescent lamps by placing the lamp in it and heating the tube with a high power air-blower (PJ-208A, Ishizaki Electric MFG).
Procedures and results
The procedures below are summarized in Figure 1 .
I. Standard Procedures

A. Preparation of solutions
Preparation of 300 µg/5 µl Bhc-dizo solution in dimethyl sulfoxide (DMSO): Approximately 900 µg of the Bhc-diazo powder is transferred from a light-shielded glass vial (stored at -20 °C) into a 1.5 ml Eppendorf plastic microtube with a small autoclaved stainless steel microspatula (No. 9-866-01, Laboran, Co.), and then precisely weighed with an electronic precision balance (AG245, Mettler). The powder is then dissolved in the appropriate volume of DMSO to make up a 60 µg/µl solution (the volume of DMSO used was 15 µl). Since caging efficiency varies according to the species of mRNA, we recommend varying the amounts of Bhc-diazo from 40 to 80 µg/µl in several preliminary experiments to identify the best conditions for the individual species of mRNA to be caged. Preparation of 10 µg/ 5 µl mRNA solution in DMSO: 10 µg of in vitro transcribed mRNA is precipitated with an equal volume of isopropyl alcohol and 1/10 volume of 10 M ammonium acetate, and then washed with 200 µl of 70% ethanol in nuclease free water and dried at room temperature. A vacuum desicator should not be used, because it may excessively dry the sample, and care should be taken to completely remove the ammonium acetate to prevent a possible chemical reaction with Bhc-diazo. When the pellet has become nearly transparent, before it becomes completely dry, it is dissolved in 5 µl of DMSO. Note that an over-dried pellet cannot be dissolved in DMSO. A micropipette is then used to triturate the pellet, and it is dissolved completely by slowly pipetting up and down approximately 100 times until the solution starts to retain the air bubbles for a moment after each pipetting because of the slight increase in viscosity. B. Caging reaction A 5 µl volume of the Bhc-diazo solution is transferred to a microtube containing mRNA solution to prepare the reaction mixture (final volume 10 µl). They are mixed well by gently pipetting several times, and the mixture is incubated for 60 minutes at room temperature. As the caging reaction proceeds, the solution becomes paler than the initial slightly pink color. C. Removal of free Bhc-diazo by column chromatography A 500 µl volume of Sephadex G50 (Pharmacia) that has been allowed to swell and been washed in DMSO is loaded onto a 1 ml micropipette tip that had been plugged with cotton, autoclaved, and dried beforehand. Immediately after excess DMSO stops dripping from the tip of the column, the column is washed once with 500 µl of DMSO. To prevent the resin from drying, new solutions should always be loaded immediately after the last drop. After the reaction mixture is loaded, 200 µl of DMSO is added twice. The eluate is collected in a 1.5 ml microtube, and mixed with 500 µl of isopropyl alcohol and 50 µl of 10 M ammonium acetate. After pipetting up and down 20 to 30 times with the 1 ml micropipette, the mixture is centrifuged at 15,000 rpm for 10 min at 4 °C, and the supernatant is completely removed by aspiration with a 1 ml micropipette. The pellet appears as a dark spot of tightly packed film and is washed with 150 µl of 70% ethanol by centrifugation at 15,000 rpm for 5 min. After removal of the supernatant, the pellet is air dried but not for more than one hour. Just before microinjection, the pellet is dissolved in 5 µl of diethyl pyrocarbonate (DEPC)-treated nuclease-free water (Ambion Inc.). The pellet is difficult to dissolve in water and tends to float like a thin film in the solution. Pipetting more than 100 times is necessary, until the solution becomes viscous. The procedure for the caging reaction and column chromatography are summarized in Figure 1 . D. Injection of the caged mRNA solution into onecell stage embryos A glass microcapillary is prepared beforehand by pulling a hollow glass capillary (G-1, Narishige, outer diameter, 1 mm; inner diameter, 0.6 mm, Narishige) with a microelectrode puller (PN-30, Narishige, Heater level; 86, Magnet level; 21) ( Figure 2) . A 2 µl volume of caged mRNA solution is loaded into the capillary with the 200 Original Eppendorf Microloader 5242 956.003 (Eppendorf), and the loaded microcapillary is attached to the microcapillary holder connected to the N 2 gas-operated pressure injector (IM300, Narishige; injection pressure, 30 pico-Siemens [psi]). The holder is supported by the micromanipulator (MM-3, Narishige). The system for microinjection is illustrated in Figure 3a .
Fertilized eggs are collected and aligned on a transparent acrylic plate (custom-made by a local workshop) with V-shape grooves (Figure 3b ) that is attached with plastic adhesive tape to the bottom of a plastic Petri dish (10 cm in diameter) containing fish-breeding water. The water is removed by aspirating almost to the bottom edges of the grooves so that the surface tension of the water keeps the eggs attached to the grooves.
Fine microforceps (No. 5, Dumont) are used to manually break the tip of the microcapillary while observing it through a ×16 dissecting microscope (Stemi DRC, Carl Zeiss), so that the opening at the tip of the capillary has diameter of approximately 20 µm (Figure 2b) .
The plastic dish carrying the aligned eggs is placed on the stage of the dissecting microscope, and the caged mRNA solution is pressure injected into the yolk of the embryo at approximately 30 psi for 40 milliseconds. The pressure and duration of each injection are adjusted so that the size of the injected solution spreads to form a drop having a diameter approximately one-third that of the cytoplasm. Since the caged mRNA solution is very viscous, the capillary usually becomes stuck after injection into 20 through 30 embryos. We usually recover the residual solution by using the 200 Original Eppendorf Microloader and reload the solution into a new capillary to inject again.
The injected embryos were transferred into fish breeding water and kept in the dark at 28.5 °C. E. Uncaging At 3 through 12 hours post-fertilization (hpf), the injected embryos are aligned again on the grooves of the acrylic plate and transferred onto the stage of a microscope (Olympus BX-51 WI, http://www.olympus.co.jp/indexE.html) equipped with a ×10 objective lens (UplanApo, Olympus) (Figure 4a ). An electronically controlled shutter (F77, Suruga Seiki) installed between the pinhole plate and a 100-watt mercury lamp is used to illuminate their body parts of choice with a spot of UV light (365 nm) for one second (Figure 4a ). A plate with a pinhole of 20 µm through 400 µm in diameter is inserted at the confocal plane of the light path from the UV lamp to illuminate spots having diameters of approximately 4 through 70 µm. For example, we used a pinhole 200 µm in diameter to specifically illuminate a spot 36 µm in diameter in the forebrain of the 12-hpf embryos (Figure 4b) . No neutral density filter is inserted in the light path. Injected embryos that are either UV-illuminated for uncaging or not uncaged are both kept in the dark for several additional hours till the protein from the uncaged mRNA is synthesized.
II. Titration of caging efficiency
Since Bhc-diazo is a labile compound, the caging efficiency of Bhc-diazo varies with the batch, and its activity may be affected by storage conditions. We therefore recommend checking the titer of Bhc-diazo by the simple procedure described below before actually using Bhc-diazo for the mRNA of interest. This titration test yields results in one day and ensures that the batch of Bhc-diazo is active. We recommend use of the β-galactosidase or GFP mRNA because of the simplicity of detection of the translational product (either by histochemical staining or by simple examination with a fluorescence microscope). A. Synthesis of caged-β-galactosidase or GFP mRNA A 300 µg/5 µl solution of Bhc-diazo in DMSO and a 10 µg/ 5 µl solution of in vitro synthesized mRNA in DMSO are mixed together and allowed to react at room temperature for 30 min for β-galactosidase mRNA, and one hour for GFP mRNA. After purification, the caged mRNA is dissolved in 5 µl of nuclease-free water and injected into the one-cell stage embryos. B. Uncaging At 3 hpf, half of the injected embryos showing normal development are selected for UV-illumination of the entire blastoderm for one second with the ×10 objective lens and 25% neutral density filter installed between the pinhole plate and the UV lamp. Both the uncaged and nonuncaged injected embryos are then kept in the dark at 28.5 °C for an additional 3 to 8 hours. C. Histochemical detection of β-galactosidase activity For detection of β-galactosidase expression, the embryos are fixed at 6 hpf with 0.8% glutaraldehyde in PBS (0.1 M Phosphate, pH 7.4) for 1 hour at room temperature. After removal of the chorion, the embryos are rinsed twice with PBS. The histochemical reaction is performed according to the standard procedure at room temperature [3] . Namely, the embryos are immersed in NDP solution (0.02% NP40, 0.01% sodium deoxycholate in 0.1 M Phosphate, pH7.4). After incubation for 10 minutes at room temper- When both the caging and uncaging reactions are successful, the chromogenic reaction product should begin to appear in the entire animal pole region of the uncaged embryos within 30 min, whereas almost no staining should appear in nontreated injected (non-uncaged) embryos. Figure  5 shows the difference in the efficiency of caging and uncaging when the same amounts of either fresh (within 7 days after synthesis) or old (stored at -20 °C for 10 months) Bhc-diazo were used. When we used fresh Bhc-diazo, hardly any staining was detected in the non-uncaged embryos after an overnight chromogenic reaction ( Figure  5a ), whereas, when an old batch of Bhc-diazo was used faint staining was detected in the nonuncaged embryos only after reacting for 40 min (Figure 5c ), and the uncaged embryos injected with mRNA caged with old Bhc-diazo stained within 40 min to a level comparable to the overnight staining of the uncaged embryos injected with mRNA caged with fresh Bhc-diazo (Figure 5b, d) .
III. Modification of the procedure
To suppress leaky expression in non-uncaged embryos, we sometimes directly inject DMSO solutions of caged mRNA into the embryos. This method significantly reduces leaky expression in non-uncaged embryos, but at the same time increases the lethality of the injections, probably because of the toxicity of the DMSO. A. Synthesis of DMSO-solubilized caged GFPmRNA A 400 µg/ 5 µl volume of Bhc-diazo in DMSO and 10 µg/5 µl of GFP mRNA in DMSO are mixed and incubated for 70 min to 90 min at room temperature. After purification by the column chromatography described above, the caged mRNA is precipitated by addition of an equal volume of isopropyl alcohol and 1/10 volume of 10 M ammonium acetate. After centrifugion at 15,000 rpm at 4 °C for 10 min, the pellet is rinsed with 70% ethanol and dried in air. Before the pellet becomes completely dry, it is dissolved in 10 µl of DMSO. In contrast to when we attempted to dissolve the pellet in water, even the over-dried pellet dissolves. The DMSO solution of caged mRNA is injected into one-cell stage embryos in the same manner as described above, and the embryos are incubated at 28.5 °C in the dark.
At 3 hpf, half of the embryos showing normal development are uncaged by UV illumination of the entire animal pole for one second with a 25% neutral density filter (Figure 5f ). Or, the optic vesicle of the embryos is illuminated with spot UV for one second with no neutral density filter at 12 hpf (Figure 5g ). Both the uncaged and nonuncaged embryos are incubated in the dark, for 3 hours for the embryos uncaged at 3 hpf, and for 6 through 12 hours for the embryos uncaged at 12 hpf.
Results and discussion
As shown in the titration assay (Figure 5c-d) , old Bhc-diazo tends to produce looser caging with higher levels of expression both before and after uncaging. However, we confirmed that as long as it is stored at -20 °C, Bhc-diazo stays as active as fresh Bhcdiazo even 6 months after synthesis.
Mainly due to the reduced solubility of caged mRNA in aqueous solution, special care should be taken to completely dissolve the caged mRNA. As the number of Bhc molecules attached to mRNA increases, leaky expression of the caged mRNA Bhc-diazo, uncaged at 3 hpf, and stained for β-galactosidase activity at 6 hpf. The embryos injected with intact β-galactosidase mRNA were fixed at 6 hpf and stained for β-galactosidase activity for comparison (e). f and g, Embryos injected with DMSO solution of caged GFP mRNA visualized after UV-uncaging. (f) 11-hpf and 24-hpf embryos whose entire animal pole was uncaged at 3 hpf (left top and bottom panels) or non-uncaged (right top and bottom panels). (g) 24-hpf embryo whose optic vesicle was uncaged at 12 hpf.
decreases, but it becomes hard to dissolve in water. Therefore, direct injection of DMSO solutions of caged mRNA into embryos allows the use of caged mRNAs that have been produced using higher concentrations of Bhc-diazo. When the uncaged and non-uncaged embryos were observed at various developmental stages, the embryos injected with caged mRNA dissolved in DMSO had greatly reduced levels of leaky expression (Figure 5f, g ). The presence of DMSO in the solution injected may also help prevent the hydrolysis of the P-O bonds between Bhc and phosphate by phosphatase [4] . This method significantly reduces leaky expression in nonuncaged embryos, but at the same time increases the lethality of the injections, probably owing to the toxicity of the DMSO.
A gene 'knockdown' technology using antisense morpholino oligonucleotide (AMO) was recently developed to facilitate direct assignment of gene functions [1] . Translational repression in early-stage zebrafish embryos by injection of AMO specific to the gene transcript of interest is by far less timeconsuming and costly than gene targeting technology using embryonic mouse stem cells. Combination of AMO and mRNA caging with Bhc-diazo would be useful for elucidating the epistatic relationships of genes. For example, if a loss-of-function phenotype of gene A as a result of injection of an AMO specific to gene A could be rescued by induction of gene B by activation of the caged mRNA for gene B, then the product of gene B would be expected to play its role downstream of the product of gene A. Because of the simplicity of both technologies, their combined use would provide a powerful tool for elucidating the inter-relationships between multiple genes in a genetic network.
